LATANOPROST

Course overview

LATANOPROST IS AN EYE DROP FORMULATION FOR TREATING ELEVATED INTRAOCULAR PRESSURE (IOP) IN OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA PATIENTS. IT IS A PROSTAGLANDIN F2 ALPHA ANALOG. PROSTAGLANDINS ARE MOST COMMONLY USED AS THE FIRST LINE OF TREATMENT IN GLAUCOMA DUE TO THEIR EFFICACY IN REDUCING THE IOP, CONVENIENT ONCE-DAILY DOSING, AND ACCEPTABLE SAFETY PROFILE. IN ADDITION, THE FIXED-DOSE COMBINATION OF NETARSUDIL/LATANOPROST WAS APPROVED BY THE US FDA IN MARCH 2019 FOR OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION. THIS ACTIVITY COVERS THE MECHANISM OF ACTION, PHARMACOLOGY, INDICATIONS, ADVERSE EVENT PROFILES, CONTRAINDICATIONS, TOXICITY, AND ITS MANAGEMENT FOR LATANOPROST. IN ADDITION, IT HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF CONDITIONS WHERE LATANOPROST HOLDS THERAPEUTIC VALUE.